Bottom line
HGHAX vs HIAHX: the short answer
HGHAX (The Hartford Healthcare Fund) and HIAHX (Hartford Healthcare Hls Fund) have nearly the same top holdings — their top 25 positions are about 93% the same by weight.
HIAHX is cheaper at 0.94% vs 1.33% — a difference of $39 a year per $10,000 invested.
HGHAX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
HGHAX vs HIAHX side by side
| HGHAX | HIAHX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Hartford | Hartford |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.33% | 0.94% |
| Annual cost per $10k | $133 | $94 |
| 10-yr cost on $10k (prospectus) | $2,063 | $1,155 |
| Max front load | 5.5% | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | — | +16.1% |
| 5-yr return (annualized) | — | +3.5% |
| 10-yr return (annualized) | — | +7.9% |
| Best quarter | +20.9% | +21.0% |
| Worst quarter | −15.7% | −15.6% |
| Net assets (fund) | $772.2M | $112.4M |
| Number of holdings | 80 | 79 |
| Portfolio turnover | 49% | 5% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | HGHAX | HIAHX | Difference |
|---|---|---|---|
| 2025 | +15.6% | +16.1% | −0.5% |
| 2024 | 0.0% | +0.4% | −0.4% |
| 2023 | +3.8% | +4.1% | −0.3% |
| 2022 | −11.7% | −11.2% | −0.5% |
| 2021 | +10.0% | +10.0% | −0.1% |
| 2020 | +22.6% | +23.1% | −0.5% |
| 2019 | +33.3% | +34.0% | −0.7% |
| 2018 | −3.0% | −2.7% | −0.3% |
| 2017 | +21.6% | +22.3% | −0.7% |
| 2016 | −8.6% | −8.4% | −0.2% |
Source: Fund prospectus bar charts
Holdings overlap
23 of HGHAX's top 25 holdings also appear in HIAHX's top 25.
| Holding | HGHAX | HIAHX |
|---|---|---|
| Eli Lilly & Co | 12.03% | 12.47% |
| Johnson & Johnson | 6.75% | 6.63% |
| Merck & Co Inc | 6.00% | 6.60% |
| UnitedHealth Group Inc | 4.74% | 4.72% |
| AbbVie Inc | 4.21% | 3.43% |
| Elevance Health Inc | 3.00% | 2.96% |
| Intuitive Surgical Inc | 2.88% | 2.99% |
| CVS Health Corp | 2.84% | 2.93% |
| Vertex Pharmaceuticals Inc | 2.64% | 2.69% |
| Danaher Corp | 2.57% | 2.65% |
| Edwards Lifesciences Corp | 2.48% | 2.42% |
| Cencora Inc | 2.46% | 2.07% |
| Regeneron Pharmaceuticals Inc | 2.02% | 1.52% |
| HCA Healthcare Inc | 1.88% | 1.60% |
| Boston Scientific Corp | 1.88% | 1.19% |
Source: SEC Form N-PORT
HGHAX top 10
- Eli Lilly & Co — 12.03%
- Johnson & Johnson — 6.75%
- Merck & Co Inc — 6.00%
- UnitedHealth Group Inc — 4.74%
- AbbVie Inc — 4.21%
- Elevance Health Inc — 3.00%
- Intuitive Surgical Inc — 2.88%
- CVS Health Corp — 2.84%
- Vertex Pharmaceuticals Inc — 2.64%
- Danaher Corp — 2.57%
HIAHX top 10
- Eli Lilly & Co — 12.47%
- Johnson & Johnson — 6.63%
- Merck & Co Inc — 6.60%
- UnitedHealth Group Inc — 4.72%
- AbbVie Inc — 3.43%
- Intuitive Surgical Inc — 2.99%
- Elevance Health Inc — 2.96%
- CVS Health Corp — 2.93%
- Vertex Pharmaceuticals Inc — 2.69%
- Danaher Corp — 2.65%
FAQ
What is the difference between HGHAX and HIAHX?
Which is cheaper, HGHAX or HIAHX?
Should I own both HGHAX and HIAHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.